medical expenses

There is a difference in perspective. You are looking at the patient as a victim and NewDoc is looking at the physician as a victim. When doctors talk about shotgun cases they are talking about anyone remotely associated with a case being sued. Some doctors can be pretty far removed from a case and still be sued.

In the end, these doctors may be found not guilty. However, the process is draining, nevertheless. It takes time, costs money, increases stresses and in some cases shortens lives.

No one is against legitimate cases where patients are injured by doctor malpractice. If a person is injured, that person deserves to be compensated. Again, there is a difference of perspective where you are talking about when someone is injured by malpractice and others are talking about when someone is not injured by malpractice.
 
with no real information except Burnt's OP where he mentions not paying his bill
how could anyone equate suggesting talking with a lawyer with suing?

If Burnt doesn't pay his bill he will ultimately need some kind of expert help as he is hounded by vollection people

why not find out what his options are now?

mrDeez is correct to suggest a phone call to someone versed in this field.
 
That second article is actually pretty good. It is nice to see that some foreign companies are able to meet FDA regulations, especially in QC and QA, and export to the US. Traditionally that has not been the case.

Seeing how according to the article 428 ANDAs were approved last year, competition in generics is increasing. This competition will continue to lead to lower prices. I think you stated that there were few competitors because of under-the-table deals and I stated that the issue was not under-the-table deals but rather market dynamics. The entry of more foreign companies changes the market dynamics as they are more willing to enter low profit, competitive, and small markets.
 
Deez-
1). Your car wreck analogy starts with an assumption of another party's "carelessness," something that has not even been suggested or implied in this case (and yet... "sue the doctor" responses started.

2). Not arguing with any of the points you've made...my post is just a reaction to decades of knee-jerk "sue the doctor" statements from people who know NOTHING of the cases being discussed. Trust me, man-- it's ******* tiresome.
 
Well, I am sure you are right about these market factors being the #1 reasons for decreased competition and increased prices. I mean what other reasons could there be? And why should I not welcome your knowledge 100% when if you have already been wrong on 2 big issues on this thread. And you haven't even acknowledged the fact that you were completely wrong about them. I would be happy to provide you information into something you are not familiar or don't think to be true in the future so that you can better understand. I think this will help you learn more from other posters instead of simply posting "that is inaccurate" and other similar phrases when you really don't understand all of the dynamics and current state of generic pharmaceuticals.
 
1. Teva Pharmaceutical - Israeli company that manufactures US products in the US. 21.8% mktshare
2. Mylan - US company. 11.3% mktshare
3. Sandoz - German co that manufactures US products primarily in the US. 7.8% mktshare
4. Watson Pharmaceuticals - US co. 6.3% mktshare
5. Greenstone - Pfizer (US co.) 5.4% mktshare
6. Par Pharma - US co. 4.1% mktshare
7. Hospira - Abbott spinoff. 3.3% mktshare
8. Apotex - Canadian co. 2.8% mkt share.
9. Mallinckrodt - Covidien spinoff from Tyco US co. 2.7% mktshare
10. Dr. Reddy's - Indian co. 2.6% mktshare. Dr. Reddy's has seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications – five of them in India and two in the UK.

Cheap imports from China and India have not traditionally been a big part of the generics market in the US. Competition in generics is increasing. Lower prices will result from this increased competition. And yes, as I've stated about 20 times on this thread, market dynamics shape the generics industry pricing and availability. Please let me know what would convince you of this.The Link
 
Actually, my side-point at the time was that cheap imports from China and India weren't bringing down prices. Considering that together these companies have less than 6% marketshare, my point was correct. I knew about Dr.Reddy's and their small marketshare. I wasn't aware that the smaller Indian companies were starting to import and that is where I thanked you for the article.

But all of this is irrelevant to the point that market dynamics are driving down generic prices and that competition is based on marketing issues and not under-the-table deals. For over 15 years, I consulted, managed marketing, and managed business development in the biotech and pharmaceutical industries.

FYI, business development is responsible for licensing - biotech and pharmaceutical companies bring in new technologies, license out new technologies, divest products, re-shape product portfolios, co-market or co-develop products and business development negotiates all of these deals. As a consultant, for example, I helped Glaxo marketing shape their HIV and Cancer franchises and then helped business development streamline their portfolios to maintain growth in those areas.

As for generics, I really didn't care a whole lot other than how they might effect the sales of patent-protected products. Of course, I have met many of the business development teams of the larger companies - The smaller companies don't have teams.

The point of all this is that I am sorry that you got all butt-hurt. I didn't mean to offend your PharmD sensibilities. However, just because you package pills doesn't make you an expert in how pharmaceutical companies operate. To say that under-the-table deals rather than marketing forces are responsible for limited competition (which isn't really limited when compared to other industries) is dumb. As evidence, I showed you what a typical marketing report on generics looks like. However, obviously you didn't read it and were too butt-hurt to even bother. Oh well.
 
I hope that made you feel better. It is quite obvious that you just want to try to attack me. Good luck with that.

BTW, just some clarity since you made some mistakes in your last post. I never said that pharmaceutical companies were saints: What I said was that the driver of pricing and availability is market forces.

If you've been paying attention over the years you would have noticed a thread with suttree where I stated that an executive at Interneuron knew of the dangers of Redux and did not disclose the info. to Wyeth - this lead to the death of people. That executive then became president and CEO of another biotech company whereas I felt he should go to jail. Similarly, I left the industry about 8 years ago after the company that I was working for made changes to an FDA approved product without resubmitting the changes to the FDA. I couldn't see myself dealing with that kind of nonsense when I went into the business to help people.

Anyway, the reason I bring this up is because I am keenly aware at some point you will bring up some malfeasance by a pharmaceutical company to try and make your point. However, your point would still be wrong. The driver of prices and competition in the pharmaceutical industry is market forces not under-the-table deals and I would be surprised if anyone who worked in management in any company would disagree. Just think, if there are over 100 generic drug manufacturers that operate in the US, what kind of under-the-table deal would have a lasting effect to keep all 100 companies from trying to compete? I get sick and tired of hearing such nonsense from people who don't know what the hell they are talking about or have some sort of axe to grind against an industry. It is foolish.
 
Unfortunately, under the table deals do determine the price for pharmaceuticals. Entities known as Group Puchasing Organizations negotiate deals with manufacturers. As a result, the price for the same exact product is different depending upon where you are at. Honestly, these GPO's act largely like organized crime in my eyes - taking skim from between the manufacturers and end user consumers.

Additionally, throw in distributors and the GPO price will vary based upon volume the entity is buying. Therefore, go to a small facility with low volume and the price will be higher.

Finally, add in Class of Trade and you have a whole different pricing mechanism. Not that I have a dog in this fight, but natural market forces do not drive pharmaceutical or healthcare prices.
 
What I have seen is not paying off generic manufacturers but rather threatening them. Paying off generic companies would in most cases be counter-productive.

A drug patent is one thing, but pharmaceutical companies develop an entire patent portfolio around a product. There are patents for indications for drugs, for manufacturing of drugs, for raw materials of drugs, for formulations of drugs and of course for the chemical structure of a pharmaceutical. Literally there could be over 2 dozen patents covering a single drug. When the time gets close for the primary patent to expire on a drug, the pharmaceutical company closely monitors the generic companies. If the generic companies makes a slip, you can bet your life that the pharmaceutical company will pursue it. Even if the generic company doesn't slip, the pharmaceutical company will get its legal team involved to try to slow down the generic competition. Of course, this will only last so long but in the meantime, the pharmaceutical company can gain hundreds of millions of dollars in revenue.
 
What I've gathered from this thread is that a person who worked directly in the pharmaceutical industry knows nothing and a person who works tangentially with the pharmaceutical industry knows everything...

brickwall.gif
 
The 5 forces have little to do with these underhanded deals. And yes, generics are a big part of these deals.

However, you should be proud of your reference to Porter.
 
You must log in or register to reply here.

NEW: Pro Sports Forums

Cowboys, Texans, Rangers, Astros, Mavs, Rockets, etc. Pro Longhorns. The Chiefs and that Swift gal. This is the place.

Pro Sports Forums

Recent Threads

Back
Top